Position in JNJ
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$179,757,426
+$127,490,043 QoQ
Shares Held
707,790
+231.0% QoQ
Ownership
0.029%
of shares outstanding
% of Portfolio
1.07%
of 13F equity value
Holder Rank
#217
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Derivatives in JNJ
reported options exposure · as of Mar 31, 2024CallValue
$980,778
CallShares
6,200
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026NATIXIS holds $664,875,786 across 10 Drug Manufacturers - General names. JNJ ranks #1 (27.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
707,790 | $179,757,426 | |
| 2 | LLY |
ELI LILLY & Co
|
133,441 | $160,053,151 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
2,519,137 | $145,152,673 | |
| 4 | ABBV |
AbbVie Inc.
|
267,055 | $67,201,720 | |
| 5 | NVO |
Novo Nordisk A S
|
824,229 | $39,513,538 | |
| 6 | MRK |
Merck & Co., Inc.
|
280,187 | $36,004,029 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
143,928 | $18,183,863 | |
| 8 | PFE |
Pfizer Inc
|
632,317 | $15,226,193 |
All Filings in JNJ
Export CSV
32 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $179,757,426 | 707,790 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $52,267,383 | 213,825 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $84,796,313 | 409,743 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $195,880,283 | 1,056,414 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $97,019,620 | 635,153 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $10,086,388 | 60,820 | Shares | Sole | 2025-07-18 | |
| 2024-12-31 | $23,936,056 | 165,510 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $23,052,872 | 142,249 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $25,152,527 | 172,089 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $980,778 | 6,200 | Call | Sole | 2024-05-13 | |
| 2024-03-31 | $30,201,950 | 190,922 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $11,224,463 | 71,612 | Shares | Sole | 2024-02-13 | |
| 2023-12-31 | $971,788 | 6,200 | Call | Sole | 2024-02-13 | |
| 2023-09-30 | $965,650 | 6,200 | Call | Sole | 2023-11-14 | |
| 2023-09-30 | $13,388,580 | 85,962 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $103,667,162 | 626,312 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $105,763,010 | 682,342 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $165,047,804 | 934,321 | Shares | Sole | 2023-02-24 | |
| 2022-09-30 | $115,332 | 706 | Call | Sole | 2022-11-14 | |
| 2022-09-30 | $121,780,468 | 745,473 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $222,420 | 1,253 | Call | Sole | 2022-08-12 | |
| 2022-06-30 | $109,526,687 | 617,017 | Shares | Sole | 2022-08-12 | |
| 2022-06-30 | $32,839 | 185 | Put | Sole | 2022-08-12 | |
| 2022-03-31 | $261,522,005 | 1,475,608 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $72,705,090 | 425,002 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $227,659,927 | 1,409,659 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $74,672,027 | 453,272 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $36,039,652 | 219,286 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $173,755,388 | 1,104,050 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $262,325,517 | 1,761,993 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $62,125,974 | 441,769 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $161,329,763 | 1,230,304 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||